Topics: Part D, Medicare, Medicare Monday
From accessing medicines to intellectual property to drug safety, PhRMA is devoted to advancing public policies that support innovative medical research, improve treatments and yield real results.
Last week, we looked at what was said about Medicare Part D costs and beneficiary premiums when the program was created – and at what has actually happened in the first 10 years of the program.
This week, we’re looking at what was said about competition in Part D then and now.
Learn more about how successful competition works in Part D here, and tune in next week for our final Part D Then and Now.
Topics: Part D, Medicare, Medicare Monday
Pharmaceutical Research and Manufacturers of America®
950 F Street, NW Suite 300, Washington, DC 20004
Please be advised that this page contains pixel tags. To learn more about what pixel tags are, why and how
we and third parties use pixel tags, and how that use affects you, visit our privacy policy and review
"1. Information Collection."